logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Rexahn Pharmaceuticals (RNN) Continues to Spike on Potential Cancer Pill, Roth Upgrade

By  +Follow January 13, 2014 10:17AM
Share:
Tickers Mentioned:

Shares in Rexahn Pharmaceuticals (RNN) jumped nearly 40 percent on Monday, continuing a bull-run that has the stock up over 150 percent since Thursday and over 265 percent in the last month on a promising potential cancer treatment and the initiation of relatively bullish coverage from Roth Capital Markets analysts.

RNN’s RX-3117 Could be Alternative for Eli Lilly’s Gemzar

Driving the current growth-spurt is the announcement of the initation of Phase 1b to study the safety and efficacy of RX-3117, Rexahn’s lead drug candidate, in cancer patients with solid tumors. The hype surrounding RX-3117 is considerable given that it has to potential to function as an oral to Eli Lilly’s (LLY) Gemzar.

"The initiation of this Phase I clinical trial of RX-3117 represents an important milestone for Rexahn," said CEO Peter D. Suzdak, Ph.D. "This compound is exciting to work with, as it has a unique profile with demonstrated activity against gemcitabine-resistant human cancer cells. We were pleased to see reduced side effect liability and oral bioavailability in cancer patients in our initial exploratory Phase I clinical trial conducted in Europe, and we believe that RX-3117 may represent a significant advancement in the treatment of cancer patients with solid tumors."

Gemzar is an injectable drug that results in resistance for 1 out of 4 patients, making an alternative that functions in pill form one with considerable commercial potential.

Analyst Seems Convinced

Also helping boost shares over the past few days was the news from Thursday that Roth Capital Markets’ Joe Pantiginis had initiated coverage on the stock at a “buy” rating with a price target of $3, still nearly double the current share price even after the spike in price.

Along with the considerable potential for RX-3117, the company boasts nearly $15 million in cash as well as over $5 million in new funding, giving it enough money to carry it for two years.

 

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Liked What You Read? Join Equities.com as a contributor and get eyeballs on your content FOR FREE!

Results for rnn
Captain Sequence
26 Dec 14 03:08:35
RT @PennyHatStocks: $CYCC GM, let's start today off with a Boom!! Team Money Makers Team PennyHatStocks Team GO Green http://t.co/THKMEuXTo…
James DiPlata
26 Dec 14 03:03:07
RT @PennyHatStocks: $CYCC GM, let's start today off with a Boom!! Team Money Makers Team PennyHatStocks Team GO Green http://t.co/THKMEuXTo…
Ken
26 Dec 14 02:58:11
$CYCC GM, let's start today off with a Boom!! Team Money Makers Team PennyHatStocks Team GO Green http://t.co/THKMEuXToD $JCP $BABA $GE $RNN
Biotech Bulls
25 Dec 14 19:39:21
Here's to stockings full of $GILD $GALE $MACK $RNN $ACHN $ELTP $RXII $ $MNKD $INO $KNDI $RAD Merry Christmas :-) http://t.co/Xww5V0DO52
RangersRul
24 Dec 14 13:18:16
$RNN happy holidays to everyone. Enjoy the respite before we get to open our real gifts next year.
ThePennyCommand.com
24 Dec 14 11:58:03
http://t.co/x75OrnZD9n carp1: $RNN January Effect play.. Calling double here too!!: carp1 http://t.co/6WHmjsxMpn http://t.co/x75OrnZD9n
James DiPlata
24 Dec 14 08:50:42
RT @PennyHatStocks: $CYCC Newbies YOU BETTER BE TAKING PROFITS AND HOLDING SOME FOR NEXT WEEK $BABA $GE $FB $RNN $NSEH http://t.co/hFKtsH6x…
Ken
24 Dec 14 08:48:22
$CYCC Newbies YOU BETTER BE TAKING PROFITS AND HOLDING SOME FOR NEXT WEEK $BABA $GE $FB $RNN $NSEH http://t.co/hFKtsH6xRn
DayTraderChoice
24 Dec 14 05:11:30
DollarsOnPennies: $RNN Gallery View http://t.co/igwRxEhN0h
RangersRul
24 Dec 14 05:09:00
$RNN is fed by the pain and tears shed by those who love magnegas
_tr8dr_
23 Dec 14 10:11:06
$RNN price dead at 0.71 for more than 2 hours
RangersRul
23 Dec 14 09:07:57
$RNN is stable.... Magnegas... is not right @kokid ?
DayTraderChoice
23 Dec 14 04:23:07
DollarsOnPennies: $RNN Gallery View http://t.co/nRwdE87QjA
StockNews
22 Dec 14 14:13:37
$RNN - Statement of Changes in Beneficial Ownership (4) http://t.co/wowJyu9FFU
Ebieqd
22 Dec 14 14:13:34
$RNN - Statement of Changes in Beneficial Ownership (4) http://t.co/j0rVDZ6b2b
Stocks News&Markets
22 Dec 14 14:13:30
$RNN - Statement of Changes in Beneficial Ownership (4) http://t.co/af3NfzwCDR
RangersRul
22 Dec 14 09:33:25
$RNN This stock is Dookie @brandon123 :)
RangersRul
22 Dec 14 06:54:53
$RNN sheesh... this stock is so stable in the 70's.
TV_Trading Ideas
21 Dec 14 18:55:07
W $RNN http://t.co/J0F62NgAyh
h2fuel.mobi
21 Dec 14 18:55:07
$RNN chart: W. http://t.co/LmVBzip9kk
explodeprofits
21 Dec 14 04:01:02
DollarsOnPennies: $RNN Gallery View http://t.co/rgxWwLqzLh
Biotech Bulls
19 Dec 14 13:24:51
$RNN QQ
BigBoardScans
19 Dec 14 12:22:03
carp1: $RNN Could be a nice January play Chart http://t.co/dOvO2e3SCF
OTPicks.com
19 Dec 14 12:20:30
http://t.co/N4Q7cO9jZ9 carp1: $RNN Could be a nice January play Chart: carp1 http://t.co/8zY1aEoZBu http://t.co/N4Q7cO9jZ9
OTPICKS.COM
19 Dec 14 12:20:27
http://t.co/xnGRFOlFTe carp1: $RNN Could be a nice January play Chart: carp1 http://t.co/4r1GRwrosv http://t.co/xnGRFOlFTe
OTPicks.com
19 Dec 14 12:20:25
http://t.co/WZ6FGvJQNb carp1: $RNN Could be a nice January play Chart: carp1 http://t.co/CARkXFo8GY http://t.co/WZ6FGvJQNb
				
				
By  +Follow January 13, 2014 10:17AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.